1. India Stocks

  2. •

    Health services

  3. •

    Hospital/Nursing management
Shanmuga Hospital Limited

Shanmuga Hospital Limited

BBSE:SHANMUGA
42.00
INR
-1.00
(-2.33%)
478.77MMarket Cap
Shanmuga Hospital Limited
BSE:SHANMUGA
(Bombay Stock Exchange)

Recent

price

42.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2022
2023
2024
2025
2026
TTM
INR
30.4
28.9
31.61
45.87
34.85
- -
Revenue per Share
4.94
3.5
3.86
4.03
3.09
- -
Basic EPS, GAAP
1.41
2.17
-1.42
-5.72
-5.99
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
Dividend per Share
5.19
8.68
12.59
29.16
31.22
- -
Book Value per Share
5.19
8.68
12.59
29.16
31.1
- -
Tangible Book Value per Share
14
14
14
10
14
14
Basic Weighted Avg Shares
414
393
430
479
474
- -
Sales/Revenue/Turnover
21.53
17.05
16.94
12.71
11.52
- -
Operating Margin (%)
1
6
13
22
28
- -
Depreciation Expense
67
48
52
42
42
- -
Net Income, GAAP
25.06
27.62
25.26
26.03
25.74
- -
Effective Tax Rate (%)
16.23
12.1
12.19
8.79
8.88
- -
Profit Margin (%)
48
60
7
210
69
- -
Working Capital
- -
40
36
36
36
- -
LT Debt
71
118
171
397
425
- -
Total Equity
- -
31.88
22.16
11.93
8.38
- -
Return on Invested Capital (%)
- -
37.36
24.71
12.58
9.29
- -
Return on Capital (%)
- -
50.44
36.25
14.8
10.24
- -
Return on Common Equity (%)

Capital Structure

INR

•

in mil. unless spec.
Sep'26
Mar'26
Jun'27
ST Debt
38
31
- -
LT Borrowings
36
36
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
14
14
14
Market Capitalization
620
479
474

Working Capital

INR

•

in mil. unless spec.
Sep'26
Mar'26
Jun'27
Total Current Assets
136
125
- -
Cash, Cash Equivalents & STI
14
19
- -
Accounts Receivable, Net
62
69
- -
Inventories
30
20
- -
Total Current Liabilities
85
56
- -
Payables & Accruals
- -
- -
- -
ST Debt
38
31
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
7.06%
Free Cash Flow
- -
- -
36.54%
Net Income, GAAP
- -
- -
0.09%
Sales/Revenue/Turnover
- -
- -
-0.87%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
479
2026
115
131
- -
- -
474
2027
119
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
4.03
2026
0.7
0.78
- -
- -
3.09
2027
0.72
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -
Similar Companies
Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP)
Max Healthcare Institute Ltd (NSE:MAXHEALTH)
Fortis Healthcare Ltd. (NSE:FORTIS)
Bangkok Dusit Medical Services Public Co. Ltd. (SET:BDMS)
HCA Healthcare, Inc. (NYSE:HCA)
Yatharth Hospital and Trauma Care Services Limited (NSE:YATHARTH)
Business
Shanmuga Hospital Limited is an India-based healthcare services provider operating multi-specialty and super-specialty hospitals. Founded in 1980 and headquartered in Salem, Tamil Nadu, the company delivers comprehensive inpatient, outpatient, diagnostic, and emergency medical care across western Tamil Nadu. Shanmuga Hospital Limited operates through specialized clinical departments offering cardiology and interventional catheterization; cardiothoracic and vascular surgery; medical, surgical, and radiation oncology; orthopaedics, joint replacement, and trauma surgery; neurology and neurosurgery; nephrology, urology, and renal dialysis; medical and surgical gastroenterology; pulmonology and intensive critical care; obstetrics, gynaecology, and paediatrics; general, endoscopic, and laparoscopic surgery; 24/7 emergency, trauma, and ambulance services; diagnostic imaging, including magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, and digital radiography; clinical laboratory, biochemistry, and pathology testing; and round-the-clock in-house pharmacy operations. In recent developments, Shanmuga Hospital Limited completed an initial public offering (IPO) and listed its equity shares on the BSE SME platform to finance ongoing capital expenditures, retire debt, and procure advanced medical technologies. The company has also expanded its operational bed capacity, upgraded its intensive care and operative suites, and integrated modern minimally invasive and robotic-assisted surgical equipment to expand its specialized tertiary care capabilities.